Vol 6, No 1 (2015)
Review paper
Published online: 2015-05-14

open access

Page views 802
Article views/downloads 2867
Get Citation

Connect on Social Media

Connect on Social Media

Advances in the diagnosis and treatment of patients with chronic lymphocytic leukemia

Tadeusz Robak, Ewa Lech-Marańda, Krzysztof Warzocha
DOI: 10.5603/Hem.2015.0012
Hematologia 2015;6(1):19-30.

Abstract

Significant strides in understanding the biology of chronic lymphocytic leukaemia (CLL) have recently been made, thereby resulting in the development of more effective therapies. Several clinical trials support the key role that immunotherapy and targeted drugs play for managing patient treatment in those either newly diagnosed or with relapsed/refractory CLL. Furthermore, kinase inhibitors participating in B-cell receptor signalling pathways have been currently approved in treating patients suffering this condition. A summary review is hereby presented describing the most relevant achievements made within this field over the last 5 years.




Hematology in Clinical Practice